Safety Study for an All-in-One Body and Personal Lubricant
A Single-center, Medically Supervised, Safety Evaluation Study of an All-in-One Body and Lubricant Product
1 other identifier
interventional
70
1 country
1
Brief Summary
This is a one-week study designed to test the safety of an all-in-one body and personal lubricant product during in-home use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2010
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 25, 2010
CompletedFirst Posted
Study publicly available on registry
August 26, 2010
CompletedResults Posted
Study results publicly available
January 10, 2014
CompletedFebruary 27, 2017
January 1, 2017
Same day
August 25, 2010
April 26, 2013
January 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Subjects With Irritation Score of "0" at Baseline and One Week
Severity of irritation on a scale from 0 (No Irritation) to 6 (Presence of Lesions). Since a score of 0 is required at baseline for inclusion in the trial, this score represents a change from baseline and the trial is considered baseline-controlled.
Baseline and One Week
Study Arms (1)
Formula PD-F-7619
EXPERIMENTALAt least twice per week for one week, massage about a dime-sized amount of the PD-F-7619 personal lubricant product to the application site as directed.
Interventions
Off-White to Beige Lotion
Eligibility Criteria
You may qualify if:
- Normal, healthy adults in a stable, monogamous, ongoing heterosexual relationship with current partner within protocol-specified parameters
- Subjects comfortable discussing sensitive topics such as personal hygiene, menstruation and sexuality
- Able to read and understand English
- Voluntarily signs an Informed Consent document after the trial has been explained
- Willing to follow all study procedures, including birth control requirements
You may not qualify if:
- Any medical or mental health history or condition, or use of any product, drug or medication that per protocol (or in the opinion of the Investigator) might compromise the participant's safety or the analysis of results
- Participation as a research subject in a different trial within timelines dictated by protocol
- Participants with relationships or employment outside protocol-defined parameters
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Concentrics Research
Indianapolis, Indiana, 46240, United States
Results Point of Contact
- Title
- Joyce Hauze, Sr. Specialist
- Organization
- Johnson & Johsnon Consumer and Personal Products Worldwide
Study Officials
- STUDY DIRECTOR
Sherryl Frisch
Johnson & Johnson Consumer and Personal Products Worldwide
- STUDY DIRECTOR
Melissa Israel
Johnson & Johnson Consumer and Personal Products Worldwide
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2010
First Posted
August 26, 2010
Study Start
June 1, 2010
Primary Completion
June 1, 2010
Study Completion
August 1, 2010
Last Updated
February 27, 2017
Results First Posted
January 10, 2014
Record last verified: 2017-01